Dr Jeroen Dekervel, a GI oncologist at UZ Leuven, and Dr Francesco Sclafani, a...
Dr Francesco Sclafani, a GI oncologist at Institut Jules Bordet, Hôpital...
The RATIONALE-306 study, a global trial involving both East Asian and Western...
The CodeBreak 300 is the first phase 3 trial including chemorefractory patients...
Depending on the molecular profile of the tumour different treatment options...
The upcoming episode for WND in GI cancer will focus on the groundbreaking...
Prof Eric Van Cutsen from University Hospitals Leuven is invited by Prof Marc...
In the KEYNOTE 811 study, a randomised, double-blind phase 3 trial, the...
The absence of efficacious interventions for advanced, chemotherapy-refractory...
The SUNLIGHT trial undertook a comparative investigation of metastatic...